STOCK TITAN

Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Asensus Surgical, Inc. (ASXC) to present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
Positive
  • None.
Negative
  • None.

RESEARCH TRIANGLE PARK, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient, announced that the management team will participate and present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024 at 3:00pm EST (12:00 PM PST).

Event: 42nd Annual J.P. Morgan Healthcare Conference

Date: Thursday, January 11, 2024

Time: 12:00 PM PST

A live audio webcast of the conference presentation will be available online on the investor relations page of the Company’s website at https://ir.asensus.com/events-and-presentations. Replays of the webcasts will be archived on the website for approximately 30 days.

About Asensus Surgical, Inc.

Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™ by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. Based upon the foundations of Digital Laparoscopy and the Senhance® Surgical System, the Company is developing the LUNA™ Surgical System, a next generation robotic and instrument system as a foundation of its Digital Surgery solution. These systems will be powered by the Intelligent Surgical Unit™ to increase surgeon control and reduce surgical variability. With the addition of machine vision, Augmented Intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. The Senhance Surgical System is now available for sale in the US, EU, Japan and select other countries. For a complete list of indications for use, visit: www.senhance.com/indications. To learn more about Performance-Guided Surgery, and digital laparoscopy with the Senhance Surgical System visit www.asensus.com.

Follow Asensus

Email Alerts: https://ir.asensus.com/email-alerts

LinkedIn: https://www.linkedin.com/company/asensus-surgical-inc

Twitter: https://twitter.com/AsensusSurgical

YouTube: https://www.youtube.com/@AsensusSurgical

Vimeo: https://vimeo.com/asxc

TikTok: https://www.tiktok.com/@asensus_surgical

INVESTOR CONTACT:

Mark Klausner or Mike Vallie, 443-213-0499

invest@asensus.com

MEDIA CONTACT:

Dan Ventresca

Matter Communications

AsensusPR@matternow.com

617-874-5488


FAQ

When is Asensus Surgical, Inc. (ASXC) presenting at the 42nd Annual J.P. Morgan Healthcare Conference?

Asensus Surgical, Inc. (ASXC) will present at the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024 at 3:00pm EST (12:00 PM PST).

Where can I access the live audio webcast of Asensus Surgical, Inc. (ASXC) presentation?

The live audio webcast of the conference presentation will be available online on the investor relations page of the Company’s website at https://ir.asensus.com/events-and-presentations.

How long will the replays of the webcasts be available for Asensus Surgical, Inc. (ASXC) presentation?

Replays of the webcasts will be archived on the website for approximately 30 days after the presentation.

Asensus Surgical, Inc.

NYSE:ASXC

ASXC Rankings

ASXC Latest News

ASXC Stock Data

70.80M
266.72M
1.97%
9.32%
6.53%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
DURHAM

About ASXC

asensus aps is a computer software company based out of 22a vallensbækvej, brondby, capital region of denmark, denmark.